SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Eli Lilly and Company Announces New Data Further Exploring Mechanistic Differences Between FORTEO® (Teriparatide [rDNA Origin] Injection) and Zoledronic Acid